Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hanna J Johnsson

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Clinical and Experimental Rheumatology|October 17, 2015
Interleukin-12 and interleukin-23 inhibition in psoriatic arthritisHanna J Johnsson, Iain B McInnes
The Journal of Rheumatology|August 5, 2025
The Scientific Method and Advancing Omic Technologies: Breakthroughs in Psoriatic DiseaseHanna J Johnsson, Stephen R Pennington, Nicole L Ward
The Journal of Rheumatology|July 7, 2023
Interleukin (IL)-17 Versus IL-23 Inhibitors: Which Is Better to Treat Patients With Moderate-to-Severe Psoriasis and Mild Psoriatic Arthritis in Dermatology Clinics?Rosario Agüero, Michael J Woodbury, Kathryn Lee, et al.
The Journal of Rheumatology|August 15, 2025
Young-GRAPPA 2024: Progress, Achievements, and Strategic DevelopmentsAndre L Ribeiro, Gizem Ayan, Hanna J Johnsson, et al.
The Journal of Rheumatology|July 15, 2024
Young-GRAPPA 2023: The Future Is BrightHanna J Johnsson, Gizem Ayan, Roxana Coras, et al.
The Journal of Rheumatology|July 15, 2023
Young-GRAPPA (Y-GRAPPA) at the 2022 GRAPPA Annual Meeting: One Year in Y-GRAPPA. Where Do We Stand, Where Do We Go?Gizem Ayan, Roxana Coras, Rachel Grynszpan, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Clinical and Experimental Rheumatology|October 17, 2015
Interleukin-12 and interleukin-23 inhibition in psoriatic arthritisHanna J Johnsson, Iain B McInnes
The Journal of Rheumatology|August 5, 2025
The Scientific Method and Advancing Omic Technologies: Breakthroughs in Psoriatic DiseaseHanna J Johnsson, Stephen R Pennington, Nicole L Ward
The Journal of Rheumatology|July 7, 2023
Interleukin (IL)-17 Versus IL-23 Inhibitors: Which Is Better to Treat Patients With Moderate-to-Severe Psoriasis and Mild Psoriatic Arthritis in Dermatology Clinics?Rosario Agüero, Michael J Woodbury, Kathryn Lee, et al.
The Journal of Rheumatology|August 15, 2025
Young-GRAPPA 2024: Progress, Achievements, and Strategic DevelopmentsAndre L Ribeiro, Gizem Ayan, Hanna J Johnsson, et al.
The Journal of Rheumatology|July 15, 2024
Young-GRAPPA 2023: The Future Is BrightHanna J Johnsson, Gizem Ayan, Roxana Coras, et al.
The Journal of Rheumatology|July 15, 2023
Young-GRAPPA (Y-GRAPPA) at the 2022 GRAPPA Annual Meeting: One Year in Y-GRAPPA. Where Do We Stand, Where Do We Go?Gizem Ayan, Roxana Coras, Rachel Grynszpan, et al.
Pageof 1